HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin
Title:
HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin
Author:
Rugo, H. Barve, A. Waller, C. Bronchud, M.H. Herson, J. Yuan, J. Manikhas, A. Bondarenko, I. Mukhametshina, G. Nemsadze, G. Parra, J. Abesamis Tiambeng, M.L. Baramidze, K. Akewanlop, C. Vynnychenko, I. Sriuranpong, V. Mamillapalli, G. Ray, S. Yanez Ruiz, E.P. Pennella, E.